<DOC>
	<DOCNO>NCT00413413</DOCNO>
	<brief_summary>This study evaluate safety efficacy fix combination valsartan/amlodipine adult patient mild moderate hypertension .</brief_summary>
	<brief_title>Efficacy/Safety Valsartan Plus Amlodipine Valsartan Alone Patients With Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Male female outpatient &gt; = 18 year &lt; 86 year Patients essential diastolic hypertension At visit 1 , patient must mean sit diastolic blood pressure &gt; = 95 mmHg &lt; 10 mmHg ; patient treat antihypertensive medication must mean sit diastolic blood pressure &lt; 100 mmHg At visit 2 , patient must mean sit diastolic blood pressure &gt; = 95 mmHg &lt; 100 mmHg At visit 3 , patient must mean sit diastolic blood pressure &gt; = 90 mmHg &lt; 110 mmHg Severe hypertension &gt; = 180/110 mmHg Known suspect contraindication , include history allergy hypersensitivity valsartan amlodipine drug similar chemical structure Inability discontinue prior antihypertensive medication safely maximum period 28 day prior Visit 2 History hypertensive encephalopathy , cerebrovascular accident transient ischemic attack , myocardial infarction type revascularization Malignant hypertension All patient Type I diabetes patient Type 2 diabetes well control base investigator 's clinical judgment Pregnant nursing woman History heart failure Angina pectoris Second third degree heart block Life threaten symptomatic arrhythmia Clinically significant valvular heart disease Evidence secondary form hypertension Known moderate malignant retinopathy Evidence hepatic disease Evidence renal impairment Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Hypertension , valsartan , amlodipine , high blood pressure</keyword>
</DOC>